Pharmaceutical, Healthcare and Payer Business Solutions

Block

NEW

PAYER, PROVIDERS AND PHARMACIES

HEALTHCARE

PHARMA

We Answer the “What” and the “Why” of

Market Access.

LET'S TALK

Solutions for Pharmaceutical Manufacturers

Our customers rely on our industry-leading data and insights and cutting-edge technology to overcome barriers to access.

LEARN MORE

Solutions for
Healthcare IT

Let our unbeatable covered lives methodology and innovative technology inform your market access strategy.

LEARN MORE

Solutions for Payers, Providers and Pharmacies

Establish reimbursement policies, formulary positioning and access financial assistance that make therapies affordable for patients.

LEARN MORE

New Solution Highlights

We analyze market access trends and market readiness challenges while providing brand and market access solutions to navigate the changing healthcare market.

LEARN MORE

Slide 1

Insights

Unleash the Power of Real-World Data

MMIT helps pharma companies harness the power of real world data to better understand the patient journey.

LEARN MORE

Slide 1

Conference

AMCP Nexus 2023

We’re looking forward to sharing how our solutions can help overcome top business challenges.

SCHEDULE A MEETING

Slide 1

Infographic

Specialty Carveout Alternative Funding Vendor Syndicated Report

Learn more about why it is critical for manufacturers to understand these vendors and patient access implications, in order to formulate a response strategy to ensure appropriate therapy coverage and optimal patient access.

DOWNLOAD

Slide 1

Insights

Intelligent Insights

Our Zitter Insights Panel uses research to illuminate the complexities of market access.

LEARN MORE

Block

BioPharma Dive Webinar

Real-World Data: Overcoming the Chasm Between Payer Policy and Real-Life Practice

October 17, 2023 | 2:00pm EDT

How can your pharma company leverage RWD to strengthen your market access strategy? Watch the webinar to learn how.

Days

Hours

Minutes

Seconds

Slide 1

Industry Leading Insights

MMIT offers a range of publications for pharma, payers and providers covering news, strategy and insights across the spectrum. Our in-house journalism division AIS Health provides objective news and analysis of industry trends while RJ Health provides a comprehensive look at industry updates as they apply to medically covered drug reimbursement processes.

Slide 5

"We need doctors to fight the good fight so that any patient who needs the therapy can get the therapy, and MMIT plays a key role in that process. We need you to help us fulfill our mission for our patients."

Vice President of Market Access

Small Pharma Company

Slide 2

"As a small company, we appreciate the flexibility and responsiveness of the MMIT team. Their customer support team has done a great job working with our new hires to get them trained on their solutions."

Mark Devlin

Vice President, Head of Market Access | Phathom Pharmaceuticals

Slide 1

“Ryan [Witherington] and the team at MMIT have been great partners in our initiatives to analyze and communicate payer policy data for our product through innovative field tools, both MMIT-developed and developed by us using MMIT data. FormTrak Web, in particular, has been well-received by our field sales team and we are excited to transition to FormTrak in Veeva to streamline the process and make it an even more valuable tool.”

Director of Market Access

Large Pharma Company

Slide 3

“DHP provided us a list that was stronger than what we typically begin with, which, in turn, lowered the amount of time spent on payer that didn’t fit our profile.”

Erin Studstill

Vice President of Operations and Technology | MarketLauncher

Slide 4

"Throughout my 10 years in market access, I've been exposed to most of the top solutions, at times simultaneously. I've always found myself turning to MMIT because of their products' ease of use and data integrity."

Jai Persico

National Account Executive | Neurocrine Biosciences

TL 5

Thought Leadership

How Are Payers Reacting to Insulin Price Caps?

Over the past two decades, skyrocketing list prices for insulin have threatened medication adherence for the estimated 7.4 million American diabetics who rely on insulin to manage their disease.

TL 1

Thought Leadership

Uncovering the Patient Journey: Four Ways that Real-World Data Offers Value

For manufacturers, building a static commercialization strategy will only take you so far.

TL 2

Thought Leadership

Spotlight on Vaccines: 2023’s RSV Immunization Approvals

Manufacturers and payers have a role to play in educating patients and providers about the importance of immunizations to combat RSV.

TL 3

Thought Leadership

Preparing for Launch: How to Choose the Best Market Access Analogs

Many pharma companies are surprised to realize that payer coverage is more limited than anticipated, especially in highly competitive markets.

TL 4

Thought Leadership

What Pharma Wants to Know About the Inflation Reduction Act

Ever since the Inflation Reduction Act (IRA) became law, pharma companies have struggled to identify how these changes will affect their business.

TL 6

Thought Leadership

What Pharma Wants to Know About the Medicare Drug Price Negotiation Program

Since the passing of the Inflation Reduction Act (IRA) last fall, pharma companies have been bracing for the impact of its provisions.

Subscribe to MMIT's Thought Leadership

Get the latest from MMIT’s leading subject matter experts, receiving the latest posts right to your inbox. Top-quality thought leadership 100% free.

subscribe today

News and Media

Drug Channels

How Payers Are Reacting To Insulin Price Changes

September 15, 2023

Insulin price caps and list price reductions are a huge step forward for patient access. But what will these changes mean for health plans?

Contract Pharma

Solving Pharma’s Underlying Rebate Leakage Problem

September 13, 2023

Rebate leakage drains millions in revenue from pharma companies every year. To ensure contract compliance, manufacturers can implement these five steps.

Drug Channels

ICER Review Leads to Formulary Changes

September 13, 2023

Buy-and-bill remains the most common distribution channel for provider-administered oncology drugs, but pharmacy channels are still significant, especially for hospital outpatient departments.

STAT

Uncovering The Patient Journey: Four Ways Real-World Data Offers Value

September 12, 2023

Infusing a commercialization strategy with real-world data provides a more holistic view of the patient journey.

Modern Healthcare

Helping payers and providers grow amid volatility: Leveraging data to improve the care experience

July 1, 2023

Preliminary data indicate that 2023 may prove to be the most volatile year for health plan enrollment in a decade.

Biopharma Dive

BioPharma Dive

Pfizer’s RSV Vaccine Wins FDA Approval in Older Adults

May 31, 2023

The shot’s clearance comes several weeks after the regulator made GSK’s Arexvy the first vaccine for RSV in the U.S.

BioPharma Dive

How Real-World Data Helps Manufacturers See the Complete Market Access Story

May 15, 2023

Over the past few decades, pharma companies have perfected the art of using market access data to support product launches, negotiate payer discounts, and secure preferred status and positioning.

Consumer Affairs

Can Anything Be Done to Bring Down Prescription Drug Costs?

May 5, 2023

The Senate Health, Education, Labor and Pensions (HELP) Committee went to work this week to find a bipartisan consensus on measures to reduce prescription drug costs.

Pharmacy Times

Pharamacy Times

Adult Vaccinations and Decentralization of Health Care: How to Navigate the Landscape

May 5, 2023

Vaccination is especially important for older adults with any chronic health conditions because vaccines can prevent serious illness and resulting complications down the road.

Press Release

MMIT Announces Winners of the Eighth-Annual Specialty Pharmacy Patient Choice Awards

May 4, 2023

Four leading specialty pharmacies honored for their dedication to the highest quality customer service.

Drug Channels

Press Release

MMIT Announces Finalists of the Eighth-Annual Specialty Pharmacy Patient Choice Awards

April 11, 2023

Twelve specialty pharmacies recognized for their dedication to top-quality customer service.

Press Release

Drug Channels

Key Trends in Medical Benefit Contracting and Value-Based Agreements

April 7, 2023

In recent years, the rising cost of specialty pharmaceuticals has motivated payers to implement tighter restrictions and seek both traditional and value-based contracts with manufacturers.

Press Release

MMIT Announces the Winners of the Q4 2022 Patient Access Awards

March 30, 2023

Payers and physicians recognize manufacturers across seven therapeutic areas who are dedicated to smoothing patient access.

Fierce Healthcare

Staying Competitive in an Expanding Medicare Advantage Market

March 13, 2023

By the end of 2023, more than half of the total Medicare population is expected to be enrolled in Medicare Advantage (MA), which has climbed from 25.2 million members in 2020 to 31.5 million members today.

Drug Channels

Copay Accumulator and Maximizer Update: Adoption Plateaus as Insurers Battle Patients Over Copay Support

February 22, 2023

Our latest update finds that for 2022, about 40% of commercial lives have adopted these benefit designs.

Healthline

Biosimilar Drugs to Humira Are Arriving: Why Prices Won't Be Significantly Lower

February 3, 2023

Humira, the best-selling drug used to treat multiple forms of arthritis and other conditions such as ulcerative colitis and Crohn’s disease, finally has some competition.

Drug Channels

The Evolution of Medical Benefit Contracting: How Pharma Can Prepare

January 27, 2023

Given the growth of specialty pharmaceuticals, manufacturers will need to develop more aggressive contracting strategies to secure optimal market access for their medical benefit drugs.